| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Eczema | 8 | 2 | |
| Psoriatic plaques (scaly patches) | 2 | 0 | |
| Atopic dermatitis | 1 | 0 | |
| Dyshidrotic eczema (pompholyx) | 1 | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 2 |
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Eczema | 8 | 2 | |
| Psoriatic plaques (scaly patches) | 2 | 0 | |
| Atopic dermatitis | 1 | 0 | |
| Dyshidrotic eczema (pompholyx) | 1 | 1 |
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 2 |